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Mental Health Coverage
Parity
For some mental health advocates, first the glad
tidings: “The day of mandated mental health coverage
parity is nigh!” Next, the dose of realism: in the era of
managed care, the parity proposals before Congress
may not do very much to improve access to mental
health services.
As mental health advocates continue campaigning
to mandate parity in coverage of mental health services at both the state and federal level, changes in the
marketplace seem to have blunted the impact of these
laws. Mental health parity laws typically attempt to
open up access to mental health services by pushing
back demand-side controls on utilization. Over the
past decade, however, employers and insurers have
instituted supply-side cost controls (also known as
managed care), such as utilization review, case management, financial incentives for providers, mental
health budget caps, determinations of medical necessity, and other methods. Because most Americans with
mental health coverage receive it under some sort of
managed care regimen, achieving parity in coverage
levels for lifetime and annual dollar limits, outpatient
visits, and hospital days can be achieved at a modest
cost. The cost of pushing back these demand-side cost
controls is often low because management techniques
now employed to control costs operate independently
of them. While mental health parity laws may lead to
better financial protection for a small number of very
sick people, supply-side management techniques have
assured that spending patterns for the larger population are controlled.
Yet managed mental health strategies, which are
applied to most Americans’ health benefits, whether
they realize it or not, raise a series of new issues that
policymakers need to consider alongside parity in
benefit design. As managed care dramatically lowers
the cost of inpatient and outpatient mental health
services paid for by health plans, economists still do not
well understand how managed behavioral health
programs may have affected spending on psychotropic
drugs and general medical care. Questions also have
arisen about the impact of managed behavioral health
care on quality and access to care. Just as they did in the
old and more costly indemnity insurance system,
policymakers are now struggling to understand what the
appropriate level of spending should be for mental

health services under managed care. And they have
little data to help them.
At this Forum meeting, participants will explore the
apparent “disconnect” between political battles over
mandating parity in benefit design and developments in
the marketplace. Beginning with a discussion of the
cost and market effects of parity laws, the focus will
then turn to public policy issues raised by managed
mental health care, including concerns about access to
care, quality of care, and consumer protection.

PARITY LAWS
The Mental Health Parity Act of 1996
The parity bills now before Congress would build on
the Mental Health Parity Act of 1996, which became
effective January 1, 1998, and sunsets September 30,
2001. Often criticized for containing so many exceptions as to be ineffectual, the 1996 law prohibits employers and insurers from imposing annual or lifetime
dollar limits on coverage for mental health benefits that
are more restrictive than those applied to medical
benefits.1 A scaled-down version of a full parity bill
sponsored by Sens. Pete Domenici (R-N.Mex.) and
Paul Wellstone (D-Minn.), the law exempts the plans of
employers with 50 or fewer employees. Also exempted
are group plans that experience an increase in health
benefit costs of 1 percent or more because of the
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requirements. Employers not exempted can avoid the
cost impact of the parity legislation by redesigning
benefit packages. For example, they may increase
employee cost sharing or limits on inpatient or outpatient visits or they may implement managed care
programs. The law does not require employers to offer
mental health coverage. So they may drop mental health
benefits (or their entire health benefit package, for that
matter), if parity mandates are perceived as too onerous.
Tucked in an appropriations bill, the 1996 parity act
utilizes a regulatory structure Congress had established a
few months earlier in the Health Insurance Portability and
Accountability Act (HIPAA).2 Under this structure, states
have the option of enforcing federal mandates directed at
insurers and are not preempted from adding regulations
that are consistent with the federal floor. Unless states
pass enabling legislation and actively enforce the law,
enforcement duties fall on DHHS’ Health Care Financing
Administration. While 45 states have assumed enforcement responsibility for HIPAA’s main provisions, only
about one-third have done so for the mental health parity
requirements for insurers, in part because the requirements themselves are generally perceived as ineffectual,
according to several state regulators.3
More than 20 states have passed mental health parity
laws, ranging from measures that simply mirror the
federal statute to those that impose far stricter requirements. So far this year, governors in six states have
signed legislation expanding private-sector mental
health coverage.4 These state laws cannot be applied to
self-insured, private-sector health plans governed by the
Employee Retirement Income Security Act of 1974
(ERISA) but may apply to insurers providing services to
ERISA plans. There is a great deal of variability among
the state parity laws. Many of the more recent measures
establish coverage parity for mental conditions with a
biological basis. Some state laws apply only to certain
populations (state employees, for example).

Costs of Parity
While opponents of the 1996 Domenici-Wellstone
full parity proposal claimed that it would cause health
plan premium increases ranging from 3.0 percent to
11.4 percent, these estimates were generated on models
assuming utilization in an environment with a low
penetration of managed care. The Congressional
Budget Office estimated that premiums would increase
about 4 percent under the Domenici-Wellstone full
parity bill and 0.16 percent under the limited parity
measure that Congress eventually enacted.

Recent analyses show that the cost estimates of full
parity may have been overblown because of both the
ability of managed care to reduce mental health benefit
costs and the penetration of managed care in the marketplace. Examining 1995 and 1996 claims data from
24 managed care carve-out plans offering “unlimited”
mental health coverage with minimal co-payments (full
parity), Roland Sturm of RAND found that overall costs
increased only by about $1 per enrollee per year and
concluded that assumptions used in the 1996 debates
over parity overstated actual managed care costs by a
factor of 4 to 8.5 In the plans studied, costs were reduced by lower rates of hospitalization, a relative shift
to outpatient care, and lower payments per service.
Last year, a National Advisory Mental Health
Council (NAMHC) work group simulated the costs of
moving to full parity using a model developed by the
Hay Group.6 Incorporating some of the more recent
findings about the impact of managed care on costs, the
model predicts that if an indemnity or PPO plan moved
to full parity (absent a managed-care carve out) mental
health costs would more than double, rising from $8 per
member per month (PMPM) to $17 PMPM. Implementing full parity in a managed care carve-out would
increase costs from $4 PMPM to $5 PMPM, or about
25 percent, according to the simulation. Because full
parity would raise costs substantially in an unmanaged
environment, such a mandate gives health plan sponsors
and insurers a strong incentive to implement managed
mental health care if they have not done so already. The
model predicts that simultaneous implementation of full
parity and managed care would reduce costs from $8
PMPM to $5 PMPM.
NAMHC reported that implementation of parity may
accelerate the trend toward management of mental
health services. Some employer and insurer groups
argue that, by doing this, the parity mandates in effect
remove from the marketplace a benefit option that many
people may prefer. Employers and insurers are generally opposed to benefit mandates at either the state or
federal level.

More Parity on the Way
In May, the Clinton administration announced plans
to make health insurance coverage for mental illnesses
and substance abuse comparable to that for physical
ailments for more than 9.5 million federal employees,
annuitants, and family members covered by the Federal
Employees Health Benefits program (which is not
subject to the 1996 parity law). The previous month,
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bills were introduced in both the House and Senate that
would widen the 1996 parity requirements applying to
other employers and to insurers.
Legislation introduced by Reps. Marge Roukema (RN.J.), Peter DeFazio (D-Ore.), and Bob Wise (D-W.Va.)
would provide full parity for coverage of mental health
and addiction services. The Mental Health and Substance
Abuse Parity Amendments of 1999 (H.R. 1515) would
prohibit group and individual health plans from imposing
treatment limitations or financial requirements on the
coverage of mental health benefits and on the coverage of
substance abuse and chemical dependency benefits if
similar limitations or requirements were not imposed on
medical and surgical benefits. The bill would prohibit
plans from imposing limits on the frequency of treatments, number of visits, or the scope and duration of
treatment for mental health benefits if similar limitations
were not imposed on medical and surgical benefits. It
would also prohibit plans from imposing copayments,
deductibles, out-of-network charges, out-of-pocket contributions or fees, annual limits, and lifetime aggregate
limits for mental health benefits if similar requirements
were not imposed on medical and surgical benefits. The
bill, however, would not stop a group health plan from
negotiating separate reimbursement rates, establishing
different service delivery systems for different benefits, or
from managing the provision of benefits through the use
of pre-admission screening, prior authorization of services, and other such mechanisms.
While H.R. 1515's provisions would apply to
individuals diagnosed with any mental illness or substance abuse disorder, it would not require a group
health plan to provide any specific mental health
benefits. It would eliminate the sunset provision in the
1996 parity law and end the current exemption for
employers who show that their health insurance premiums rose more than 1 percent as a result of complying
with the parity act.
Domenici and Wellstone have introduced the Mental
Health Equitable Treatment Act (S. 796), which would
prohibit group health plans from setting arbitrary day and
visit limits on services for all mental disorders. It would
provide full parity, including equal co-payments, deductibles, and other out-of-pocket costs, but only for specified,
severe, “biologically based” mental illnesses. It does not
address parity for addictive disorders. As would H.R.
1515, S. 796 would remove the 2001 parity sunset
provision and the 1 percent cost exemption. It would also
expand the scope of the 1996 parity mandate by including
small businesses with 25 or more employees (the 1996
law applies to firms with 50 or more workers).

Some mental health advocates have objected to the
distinction that S. 796 makes between biologically
based mental illnesses and those seen as having other
causes.7 The bill would exclude many childhood
disorders, anxiety disorders, and mild-to-moderate
depressive disorders, as well as Tourette Syndrome and
bulimia. Illnesses categorized as eligible for full parity
would be schizophrenia, bipolar disorder, major depression, obsessive compulsive disorder, panic disorder,
post-traumatic stress disorder, autism, and other severe
and disabling biologically based mental disorders, such
as anorexia nervosa and attention deficit/hyperactivity
disorder. As of this writing the Congressional Budget
Office had yet to develop cost estimates of the impact
on premiums of either bill.

Economics behind Parity
While mental health parity is coming to legislative
fruition in an age of widespread managed mental health
care, it is a political response to an uneven benefit
design that some economists argue was justified in the
era of fee-for-service medicine financed by indemnity
insurance. In markets for most types of goods and
services, each consumer must pay the full cost of what
he or she is buying. In the case of items financed by
health insurance, individuals consume services without
the same incentive to control their spending because a
third party is paying the bills. (Political economists call
this phenomenon “moral hazard.” The “excess” spending resulting from third-party payment is eventually
shared by everyone in the insured group, thereby
reducing everyone’s welfare.)
To control spending caused by the moral hazard
phenomenon, health plan administrators and insurers
often impose costs, such as co-payments or co-insurance, that are triggered by consumption. Because the
moral hazard problem is greater for many types of
mental health services than for many types of general
medical care, an argument can be made that higher coinsurance levels are warranted for mental health care.8
(The RAND Health Insurance Experiment reported
responses to reduced cost sharing were nearly twice as
large for mental health care as those in general medical
care.) Applying higher dollar or day limits to mental
health benefits, however, is not as justifiable as a means
to control moral hazard.
Another reason that an health insurer may restrict
mental health benefits is to protect itself from adverse
selection—that is, to prevent the plan from attracting a
disproportionate number of sick people who will drive
up premium costs, thereby hurting the firm’s ability to
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compete. An argument has been advanced that the
threat of adverse selection creates an incentive to offer
too little mental health coverage and that public policymakers are justified in limiting cost-sharing techniques
applied to mental health benefits. Richard Frank, Chris
Koyanagi, and Thomas McGuire summarize the policy
dilemma brought on by the underlying economics well:
“A long-standing problem for policymakers has been to
determine whether restricted benefits for mental health
are there for a ‘good reason’ (moral hazard) or a ‘bad
reason’ (adverse selection). There is amply evidence
that both have been at work.”9
Advocates of parity argue that unequal benefit limits
should be eliminated. There is evidence of a widening
gap between coverage for physical and mental illness.10
According to the Hay Group, 57 percent of plans
surveyed had day limits on inpatient psychiatric care in
1997, up from 38 percent in 1988. In 1997, 48 percent
had outpatient visit limits, up from 26 percent in 1988.
The Hay Group also estimated that behavioral health
care benefits dropped from 6.1 percent of total benefit
costs in 1988 to 3.1 percent in 1997.11
Despite the detected increase in demand-side
controls, much of the drop in mental health benefit
spending is probably due to the impact of managed
care. By 1998, managed behavioral health firms reported a total enrollment of up to 162 million Americans (30 percent more than in 1996).12 The publication
Open Minds surveyed the industry with regard to
enrollment in five types of programs and found







36.6 million people in stand-alone behavioral health
utilization review programs (costing about $1.50
PMPM).
31.4 million people in stand-alone employee assistance programs (EAPs) (costing about $2.50
PMPM).
16.9 million people in integrated managed behavioral health/EAP programs (costing about $4.00
PMPM).
32.2 million people in non-risk-based behavioral
health network programs (costing about $1.00
PMPM).
45.1 million people in risk-based networks (costing
about $5.85 PMPM).

(The publication notes that the same person could be
counted in more than one category if different vendors
reported that they provided different services for the same
group of insured people.) Generating a total annual

revenue of more than $4 billion, the managed behavioral
health industry is dominated by a few players. In 1998,
three firms accounted for more than 60 percent of total
market share. In addition, managed behavioral health
programs operated internally by health maintenance
organizations covered 14.3 million people and had
revenues exceeding $380 million, the survey found.
While employers and insurers strive to cut mental
health costs, a case can be made that financing treatment of depression and other mental disorders can
increase worker productivity and improve corporate
financial performance. Up to 10 percent of all adults
experience clinical depression each year, costing the
nation a total of $44 billion, according to estimates in a
recent report by the Washington Business Group on
Health.13 Of this total cost, 28 percent is associated with
direct health expenditures, 55 percent with absenteeism
and reduced productivity, and 17 percent with premature mortality costs. The report also concluded that
clinical depression, which is concentrated among
people aged 25 to 44, can be effectively treated in more
than 80 percent of cases with medication and psychotherapy or a combination of the two approaches.
Estimates of the cost savings achieved by managed
mental health programs are open to question in several
ways. First, such programs typically are not responsible
for managing drug costs. Data used to analyze such
programs’ performance usually do not include the cost
of drugs, and drug costs have been rising rapidly in
recent years. One economist interviewed for this paper
said that he recently examined a set of contracts showing capitation rates of about $3.50 PMPM for mental
health services and $3.75 PMPM for psychotropic
drugs. It is not known to what degree pharmaceutical
spending or general medical spending for that matter
has changed, if at all, in response to the shrinkage in
benefit costs for inpatient and outpatient mental health
services. In order to understand trends in total mental
health costs, an analyst would have to examine at least
three factors: mental health carve-out costs, drug costs,
and the cost of mental health services rendered in a
general medical setting.

MANAGED CARE ISSUES
Some experts say that achieving parity in benefit
design has only symbolic importance. Others say it is
important in widening the parameters within which
managed care techniques are applied. And, of course, it is
important to protect very ill people from financial ruin.
Yet, while managed care has allowed parity in benefit
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design to be achievable, it has also compromised the
impact of parity. The salient question seems to be, How
good is your managed mental health care? To answer this
question, there are few answers and little data.
Managed behavioral health care tools include
capitation, financial incentives to providers, the size and
composition of provider networks, utilization review,
and case management. For such strategies to succeed,
much depends on the philosophies and motive of
management, the quality of the professionals involved,
and the coherence of incentive structures.14 According
to an executive in one of the largest managed behavioral health firms, the major firms in this field use the
general strategy of moving patients from inpatient
settings to outpatient settings where appropriate and
managing the use of medications. Case management
(concurrent review to determine medical necessity) by
these firms is much more intensive than management
techniques applied to most general medical illnesses.
The quality of care hinges in part on how much money
is allocated by plan administrators toward mental health
benefits. If capitation rates are negotiated or budgets are
set too low, quality will diminish.
A case study of the state of Ohio’s experience in
adopting full parity for alcohol, drug, and mental health
benefits for state employees found that switching from
unmanaged indemnity care to a managed care carve-out
was followed by a 75 percent drop in inpatient days and
a 40 percent drop in outpatient visits, despite the
increase in allowable benefits.15 Implementation of
managed care by far overwhelmed the impact of benefit
parity. But the authors pointed out that, “unfortunately,
that does not answer the question of which level of
service intensity meets the criterion of appropriateness.”
They also expressed concern that cost competition
might reduce care below acceptable limits. In this
instance, the state of Ohio took the rare precaution of
including minimum utilization standards in its managed
care contract (for example, stipulating a minimum of
500 outpatient visits be provided per 1,000 lives). Yet
contractual standards such as these raise many issues,
including the possibility of rigidifying inefficient
treatment patterns. The authors of the Ohio case study
note that the scientific information needed to set utilization standards is not yet available.
While mental health coverage mandates are in part
designed to overcome the paucity of benefits offered
due to insurer concerns about adverse selection, the
selection problem comes back in spades in the context
of managed care. Managed behavioral health firms
carrying financial risk to provide care have ample

means at their disposal to discourage the sickest patients
from joining or remaining in a health plan. This raises
the issue of whether capitation rates should be adjusted
for the severity of illness and how such a system might
be operated. Even if effective risk-adjustment mechanisms were developed, the incentive to select favorable
risk would remain, especially in instances where
insurers were competing with one another or where
capitation rates were relatively low.
Some mental health providers, analysts, and advocates
also question whether tight management of acute mental
health services by employers and insurers may ultimately
shift the cost of treating the sickest patients to the public
sector. A related concern is that seriously ill people might
be denied care by a health plan but still not qualify for
public-sector coverage, leaving them uninsured.
There is evidence that responsibility for financing
mental health and substance abuse services has been
shifting from the private to the public sector. From 1986
to 1996, funding from public sources increased from
about 49 percent to 54 percent of total spending for
mental health, alcohol, and other drug abuse treatment.16
Over that decade, Medicaid, Medicare, and other federal
programs became slightly more important as sources of
financing for these kinds of treatments, while the share of
funding from private insurance remained relatively
constant (about 25 to 26 percent). Treatment financed by
out-of-pocket sources decreased from 23 percent in 1986
to 16 percent 10 years later. (In 1996, mental health,
alcohol, and other drug abuse treatment cost a total of
about $79 billion. Of the approximately $36.3 billion in
private sector spending, $20.9 billion is estimated to have
come from private insurers, $12.7 billion from individuals, and $2.8 billion from other private sources. Of the
estimated $43 billion in public expenditures, Medicare
accounted for $10.7 billion, Medicaid programs $14.4
billion, other state and local programs $14.8 billion, and
other federal government programs $3 billion.)
NAMHC’s 1998 report concluded that benefit parity
alone does not guarantee improved access to mental
health care because of the strong counteracting effect of
management, noting that the “proportion of individuals
receiving mental health treatment varies considerably
across managed behavioral health plans—both before
and after the introduction of parity benefits.”17 The
report also expressed concern about variability in
quality in managed mental health care but noted that
there is some evidence that access and quality can be
maintained or improved under managed care. That
evidence is preliminary and further research is needed
to assess treatment outcomes, it concluded.
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Managed care strategies have sparked provider
complaints about very sick people being discharged
prematurely from inpatient settings, thereby driving up
readmission rates. Providers also note that many health
plans have formularies that exclude some of the most
expensive breakthrough psychiatric drugs:
For family members with schizophrenia or employees
with bipolar illness, new antipsychotic medications such
as risperidone, olanzepine or quetiapine may be excluded because of cost despite the fact that they have
fewer side effects than earlier drugs and are more
effective in preventing relapse,

wrote Steven S. Sharfstein and Sally Satel in a recent Wall
Street Journal commentary.18
Mental health advocates support several policy
interventions to ensure access to mental service in the
managed care context. These include making sure that
mental health services capitation rates are high enough to
provide appropriate levels of care.19 Other measures
include standardized benefits based on parity, public
release of comparative information on plan performance,
practice guidelines, effective and timely grievance and
appeals mechanisms, and risk-adjusted payment.20

THE FORUM SESSION
After several short presentations by the featured
speakers, the discussion will open up to include a panel
of experts, advocates, and interested parties.

Issue Questions
Among the issues to be discussed at this Forum
meeting are the following:








What has been the effect of requiring parity for
mental health benefits? Have the passage of parity
laws and the prospects of more parity legislation
speeded up the shift to managed mental health care?



What are the prospects that Congress may pass a full
parity bill this year? How might such legislation
address the parity issue with respect to managed care?

Speakers
William Goldman, M.D., is senior vice president for
behavioral health sciences at United Behavioral Health in
San Francisco. He is also a clinical professor of psychiatry
at the University of California, San Francisco. Dr. Goldman is currently a member (and immediate past chair) of
the American Psychiatric Association Council on Economic Affairs. He also serves on the UCLA/RAND
Research Center on Managed Care for Psychiatric
Disorders Advisory Board; the NIMH National Worksite
Program Research Advisory Group; and the NIMH Parity
Workgroup. Previously, Dr. Goldman served as medical
director for several managed care organizations as well as
director of mental health, drug, and alcoholism services
for the City and County of San Francisco and as Massachusetts Commissioner of Mental Health and Mental
Retardation.
Richard G. Frank, Ph.D., is professor of health
economics in the Department of Health Care Policy at
Harvard University Medical School, which he joined in
1994. He also serves as a research associate for the
National Bureau of Economic Research. Dr. Frank has
served on many national and state governmental agencies. Currently, he is a member of the Substance Abuse
and Mental Health Services Administration Advisory
Council and the MacArthur Foundation’s Mental Health
Policy Research Initiative. His primary areas of interest
include the economics of health and mental health, the
behavior of nonprofit institutions, pharmaceutical
pricing, and the financing of health services for vulnerable populations. He is currently conducting studies on
managed care design for mental health and substance
abuse, risk adjustment of capitation rates, and financial
incentives associated with medical group practices.

What problems do parity laws solve and what
problems do they create?
What are the principal mechanisms that employers
and insurers use to manage mental health costs in
today’s marketplace? What is known about the
ability of such strategies to control overall mental
health and health care costs?
In the era of managed mental health care, what new
issues have emerged for public policymakers?
Are managed care techniques applied in a different
way or more intensely to mental health services than
to other types of medical care?
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